Sandimmun Neoral

Known as: CyA NOF, CyA-NOF, neoral sandimmun 
 

Topic mentions per year

Topic mentions per year

1994-2017
051019942017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
A study was conducted to establish bioequivalence between two oral cyclosporine 100 mg capsules, Sigmasporin Microoral (Gulf… (More)
Is this relevant?
2003
2003
By using a rational formulation approach, we have tried to find the general characteristics for promising self-emulsifying drug… (More)
Is this relevant?
2002
2002
Cyclosporine A (CyA) is a standard component of immunosuppressive regimen after heart transplantation in most centres. The… (More)
  • table 2
  • table 5
Is this relevant?
2001
2001
The present study was undertaken to investigate the incorporation of lipophilic polypeptide, cyclosporin A (CsA) into lecithin… (More)
Is this relevant?
2001
2001
BACKGROUND The oral formulation of cyclosporin A (CsA)-Sandimmun-has a highly variable absorption. The development of a CsA… (More)
Is this relevant?
2000
2000
OBJECTIVE To compare the safety, tolerability and efficacy of the new oral microemulsion formulation of cyclosporin A (CyA… (More)
Is this relevant?
1999
1999
Objective: Bilateral cyclosporin A (CsA) and diltiazem pharmacokinetic interactions have previously been investigated, however… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
1998
1998
AIM To investigate the efficacy, tolerability and safety of a new oral formulation of Sandimmun-Sandimmun Neoral in severe… (More)
Is this relevant?
1995
1995
The new galenic formulation of cyclosporine prepared as microemulsion (Sandimmun Neoral, SN) shows a significantly improved… (More)
Is this relevant?
1994
1994
The current therapy with Sandimmun has been improved by the development of a new oral formulation of its active ingredient… (More)
Is this relevant?